PMM2

From Wikipedia, the free encyclopedia


Phosphomannomutase 2
PDB rendering based on 2amy.
Available structures: 2amy
Identifiers
Symbol(s) PMM2; CDG1; CDG1a; CDGS
External IDs OMIM: 601785 MGI1859214 HomoloGene257
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 5373 54128
Ensembl ENSG00000140650 ENSMUSG00000022711
Uniprot O15305 Q545N8
Refseq NM_000303 (mRNA)
NP_000294 (protein)
NM_016881 (mRNA)
NP_058577 (protein)
Location Chr 16: 8.8 - 8.85 Mb Chr 16: 8.55 - 8.57 Mb
Pubmed search [1] [2]

Phosphomannomutase 2, also known as PMM2, is a human gene.[1]

Phosphomannomutase 2 catalyzes the isomerization of mannose 6-phosphate to mannose 1-phosphate. Mannose 1-phosphate is a precursor to GDP-mannose necessary for the synthesis of dolichol-P-oligosaccharides. Mutations in the gene have been shown to cause defects in the protein glycosylation pathway manifest as carbohydrate-deficient glycoprotein syndrome type I.[1]

[edit] References

[edit] Further reading

  • Matthijs G, Schollen E, Heykants L, Grünewald S (2000). "Phosphomannomutase deficiency: the molecular basis of the classical Jaeken syndrome (CDGS type Ia).". Mol. Genet. Metab. 68 (2): 220–6. doi:10.1006/mgme.1999.2914. PMID 10527672. 
  • Jaeken J, Matthijs G (2002). "Congenital disorders of glycosylation.". Annual review of genomics and human genetics 2: 129–51. doi:10.1146/annurev.genom.2.1.129. PMID 11701646. 
  • Martinsson T, Bjursell C, Stibler H, et al. (1995). "Linkage of a locus for carbohydrate-deficient glycoprotein syndrome type I (CDG1) to chromosome 16p, and linkage disequilibrium to microsatellite marker D16S406.". Hum. Mol. Genet. 3 (11): 2037–42. PMID 7874123. 
  • Matthijs G, Schollen E, Pirard M, et al. (1997). "PMM (PMM1), the human homologue of SEC53 or yeast phosphomannomutase, is localized on chromosome 22q13.". Genomics 40 (1): 41–7. doi:10.1006/geno.1996.4536. PMID 9070917. 
  • Matthijs G, Schollen E, Pardon E, et al. (1997). "Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome).". Nat. Genet. 16 (1): 88–92. doi:10.1038/ng0597-88. PMID 9140401. 
  • Schollen E, Pardon E, Heykants L, et al. (1998). "Comparative analysis of the phosphomannomutase genes PMM1, PMM2 and PMM2psi: the sequence variation in the processed pseudogene is a reflection of the mutations found in the functional gene.". Hum. Mol. Genet. 7 (2): 157–64. PMID 9425221. 
  • Matthijs G, Schollen E, Van Schaftingen E, et al. (1998). "Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A.". Am. J. Hum. Genet. 62 (3): 542–50. PMID 9497260. 
  • Kjaergaard S, Skovby F, Schwartz M (1998). "Absence of homozygosity for predominant mutations in PMM2 in Danish patients with carbohydrate-deficient glycoprotein syndrome type 1.". Eur. J. Hum. Genet. 6 (4): 331–6. doi:10.1038/sj.ejhg.5200194. PMID 9781039. 
  • Bjursell C, Wahlström J, Berg K, et al. (1999). "Detailed mapping of the phosphomannomutase 2 (PMM2) gene and mutation detection enable improved analysis for Scandinavian CDG type I families.". Eur. J. Hum. Genet. 6 (6): 603–11. doi:10.1038/sj.ejhg.5200234. PMID 9887379. 
  • Kondo I, Mizugishi K, Yoneda Y, et al. (1999). "Missense mutations in phosphomannomutase 2 gene in two Japanese families with carbohydrate-deficient glycoprotein syndrome type 1.". Clin. Genet. 55 (1): 50–4. PMID 10066032. 
  • Vuillaumier-Barrot S, Barnier A, Cuer M, et al. (1999). "Characterization of the 415G>A (E139K) PMM2 mutation in carbohydrate-deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping.". Hum. Mutat. 14 (6): 543–4. doi:10.1002/(SICI)1098-1004(199912)14:6<543::AID-HUMU17>3.0.CO;2-S. PMID 10571956. 
  • Kjaergaard S, Skovby F, Schwartz M (2000). "Carbohydrate-deficient glycoprotein syndrome type 1A: expression and characterisation of wild type and mutant PMM2 in E. coli.". Eur. J. Hum. Genet. 7 (8): 884–8. doi:10.1038/sj.ejhg.5200398. PMID 10602363. 
  • Imtiaz F, Worthington V, Champion M, et al. (2000). "Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1.". J. Inherit. Metab. Dis. 23 (2): 162–74. PMID 10801058. 
  • Vuillaumier-Barrot S, Hetet G, Barnier A, et al. (2000). "Identification of four novel PMM2 mutations in congenital disorders of glycosylation (CDG) Ia French patients.". J. Med. Genet. 37 (8): 579–80. PMID 10922383. 
  • Matthijs G, Schollen E, Bjursell C, et al. (2000). "Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).". Hum. Mutat. 16 (5): 386–94. doi:10.1002/1098-1004(200011)16:5<386::AID-HUMU2>3.0.CO;2-Y. PMID 11058895. 
  • Bjursell C, Erlandson A, Nordling M, et al. (2000). "PMM2 mutation spectrum, including 10 novel mutations, in a large CDG type 1A family material with a focus on Scandinavian families.". Hum. Mutat. 16 (5): 395–400. doi:10.1002/1098-1004(200011)16:5<395::AID-HUMU3>3.0.CO;2-T. PMID 11058896. 
  • Westphal V, Enns GM, McCracken MF, Freeze HH (2001). "Functional analysis of novel mutations in a congenital disorder of glycosylation Ia patient with mixed Asian ancestry.". Mol. Genet. Metab. 73 (1): 71–6. doi:10.1006/mgme.2001.3174. PMID 11350185. 
  • Heykants L, Schollen E, Grünewald S, Matthijs G (2001). "Identification and localization of two mouse phosphomannomutase genes, Pmm1 and Pmm2.". Gene 270 (1-2): 53–9. PMID 11404002.